DSAM Partners’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-23,000
Closed -$2.34M 82
2018
Q3
$2.34M Buy
+23,000
New +$2.22M 0.34% 57
2018
Q2
Sell
-44,000
Closed -$3.24M 63
2018
Q1
$3.24M Buy
44,000
+24,000
+120% +$1.8M 0.55% 34
2017
Q4
$1.41M Buy
20,000
+3,000
+18% +$216K 0.24% 46
2017
Q3
$1.06M Sell
17,000
-135,318
-89% -$8.01M 0.15% 46
2017
Q2
$8.74M Buy
152,318
+63,917
+72% +$3.76M 1.56% 23
2017
Q1
$5.38M Sell
88,401
-30,680
-26% -$1.74M 1.17% 22
2016
Q4
$6.53M Sell
119,081
-10,919
-8% -$524K 1.8% 16
2016
Q3
$5.99M Buy
130,000
+10,000
+8% +$422K 1.31% 29
2016
Q2
$4.08M Buy
+120,000
New +$3.75M 1.25% 21

Other funds holding NGVT

DSAM Partners's NGVT Position: Q4 2018 in Review

DSAM Partners sold out of Ingevity (NGVT) in Q4 2018, closing a stake of 23,000 shares — an estimated $2.34M sold.

DSAM Partners first reported a position in NGVT in Q2 2016 and held it in 9 quarters. The position peaked at $8.74M in Q2 2017. 316 funds tracked by Wall St. Rank hold NGVT as of Q4 2018.

  • DSAM Partners reported no remaining Ingevity position as of Q4 2018 after selling out during the quarter.
  • DSAM Partners sold 23,000 Ingevity shares in Q4 2018, an estimated $2.34M.
  • DSAM Partners first reported a position in Ingevity in Q2 2016 and held it in 9 quarters.
  • DSAM Partners's Ingevity position peaked at $8.74M in Q2 2017.
  • 316 funds tracked by Wall St. Rank held Ingevity as of Q4 2018.

Based on DSAM Partners's 13F filing for Q4 2018, filed 14 Feb 2019.